GSK Investigational Site

Ashland, Oregon 97520

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2, Macular Degeneration

Studies at this site

• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
• Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
• Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
• Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed